Articles tagged with Enzymes
Researchers found that knocking out a key enzyme improved post-heart attack healing and reduced chronic inflammation. The study suggests that a short-term dietary excess of polyunsaturated fatty acids may also play a role in promoting healing.
The University of Konstanz's biological chemistry working group has decoded a molecular mechanism that inhibits bacterial populations' swarming motility. This mechanism enables bacteria to produce various natural substances using minimal resources, which may aid in combating infectious diseases and antibiotic resistance.
Scientists at Joslin Diabetes Center have found that healthy individuals with diabetes develop protective enzymes against damage from high blood sugar levels. The researchers identified an enzyme called PKM2 and showed that activating it can stop abnormalities in mouse podocytes and delay diabetic kidney disease progression.
Researchers have created a promising mouse model for the devastating genetic disorder NGLY1 deficiency. The double-deletion mice survive and exhibit symptoms analogous to humans with the condition, making them useful for testing potential therapies.
When an insect touches the Venus flytrap's sensory hairs, it triggers a chain reaction involving calcium and hormone jasmonate. The plant's glands then produce acidic vesicles filled with hydrochloric acid to decompose the prey.
Researchers at UCSF discovered a specialized enzyme that destroys chitin, a tough natural material found in the environment, which accumulates in the lungs and triggers inflammatory lung disease. Mice with this enzyme deficiency developed severe lung disease, but restoring its activity cleared up symptoms.
A Washington State University researcher has found that the uterus in female mice contains enzymes that break down semen, making it less gel-like and easier to swim. The study highlights an underappreciated complication in semen liquefaction and could lead to diagnostic tools for unexplained infertility.
Researchers have synthesized and evaluated three novel aldose reductase inhibitors, showcasing a spirobenzopyran scaffold that inhibits the target enzyme without affecting ARL1. These results suggest a promising tool for developing effective ARIs to treat diabetic complications.
A group of giant viruses, called Klosneuviruses, were identified as acquiring components from many other viruses and proteins in an evolutionarily recent timeframe. The analysis suggests that these whopper viruses did not evolve from a cellular ancestor but rather are derived from a much smaller virus through extensive gene gain.
Researchers have successfully tested a new drug that considerably weakens the recollection of a negative experience in humans. In the study, participants who received doxycycline beforehand showed a reduction of two thirds in their emotional responses to traumatic stimuli.
Scientists uncover a potent genetic element in microorganisms that enable them to self-mutate, expanding the diversity of the tree of life. The discovery reveals how rapid evolution happens in some of Earth's smallest and most common microbes.
Researchers have discovered a molecule sent by fat cells to the fly brain that signals when energy stores are sufficient, inhibiting feeding behavior. This finding suggests a potential appetite-suppression mechanism in humans and may lead to new weight management strategies.
A new fluorescent probe developed by Michigan Technological University researchers has the potential to improve cancer surgery outcomes. The probe uses a near-infrared fluorescence that can penetrate deep tissues, reducing background noise and increasing precision for surgeons.
Scientists developed a unique type of wheat that can increase the digestibility of phosphorus and other minerals, improving health for undernourished populations. The new wheat, HIGHPHY, was tested in broilers and demonstrated improved digestion coefficients for calcium and phosphorus.
Scientists at WashU Medicine have implicated SARM1 in the self-destruction of axons, a process that leads to nerve cell damage in neurodegenerative diseases. The study suggests that blocking this pathway could slow or prevent disease progression and has implications for treating peripheral neuropathy.
Researchers at EPFL develop synthetic methods to introduce chemical modifications on huntingtin, reducing its toxicity and aggregation. The study reveals key findings on the relationship between post-translational modifications and huntingtin structure, function, and toxicity.
A team of scientists has identified a new way that gut bacteria can break down complex sugars, revealing novel enzymes with potential applications in developing pre- and probiotic products to improve human health.
Researchers at TU Graz have found that superoxide dismutase enzyme function can prevent ageing in non-aqueous batteries by eliminating singlet oxygen. This discovery could lead to the development of more efficient and sustainable battery systems.
Researchers discovered a mechanism to block amyloid-beta fragments in Alzheimer's disease, reducing levels of enzyme BACE-1. A type of nucleic acid found in healthy brains promotes its degradation, offering hope for treatment.
A novel combination of two antibiotics, ceftazidime/avibactam and aztreonam, has been shown to be effective against a high percentage of carbapenem-resistant enterobacteriaceae (CRE) specimens. The therapy works by blocking different types of enzymes that bacteria use to destroy antibiotics.
The SETD8 enzyme regulates cellular senescence, a process where cells stop proliferating due to age or stress. Lowering SETD8 increases protein synthesis and growth arrest in senescent cells, promoting metabolic activities.
Scientists at Lomonosov Moscow State University have developed nanozymes, which can degrade toxic organophosphorous compounds with high efficiency. The new technology uses an enzyme encapsulated in a biodegradable polymer coat, reducing immune responses and increasing storage stability.
Researchers discover that a small GTP-hydrolysis enzyme called Rab4 is essential for the assembly of synapses and corresponding brain functions. Reduced supply of Rab4 increases synapse formation in fruit fly neurons, which may have implications for treating Alzheimer's Disease.
A study by Indiana University researchers has identified 24 compounds with the potential to boost an enzyme in the brain that protects against dementia. Caffeine was found to increase production of this enzyme, which also shows promise in reducing the impact of harmful proteins in the brain.
A study published in Science Immunology reveals that a variant of the SP140 protein, an essential epigenetic reader protein, is lacking in patients with Crohn's disease. This deficiency triggers intestinal inflammation and impairs the immune system's response to microbial signals. The researchers found that patients with reduced SP140 ...
Researchers identified an enzyme called CYP46A1 that eliminates both cholesterol and cholestanol from the brain, reducing the formation of debilitating brain lesions. The discovery could inform clinical trials to test the enzyme's potential as a therapeutic target for these diseases.
Scientists at Tokyo Institute of Technology have identified the key enzymes responsible for oil synthesis in microalgae. The research reveals that four lysophosphatidic acid acyltransferases (LPATs) play a crucial role in the formation and growth of lipid droplets, where TAG biosynthesis occurs.
Researchers have used gene therapy to treat Fabry disease, a rare inherited enzyme deficiency that can damage major organs and shorten lifespan. The treatment involves transplanted altered stem cells with copies of the fully functional gene responsible for the missing enzyme.
Researchers have developed a new tool to accurately identify enzymes present in microbiomes and quantify their relative abundances. This breakthrough may uncover novel chemistry in the gut microbiome and provide insights into its impact on human health.
A team of researchers at Johns Hopkins Medicine has identified a crucial enzyme, RAG-2, that enables precise DNA rearrangement during white blood cell development. This process is essential for producing novel antibodies that recognize and combat viruses and bacteria.
A team of scientists led by Anandasankar Ray have identified Histone Deacetylase Inhibitor 6 (HDAC6) as a regulator of learning in fruit flies. The enzyme acts like a 'dimmer switch' to increase or decrease signal across synapses, and its role in healthy neurons is less understood.
Researchers found that inhibiting intestinal protein NCoR1 breaks down bilirubin, eliminating signs of severe neonatal hyperbilirubinemia in mice. This discovery could lead to new therapeutic approaches for preventing or treating the condition.
Lily and Yuh-Nung Jan receive $100,000 prize for their discoveries on neural development, vision, and hearing; Michaela Gack, Michael Halassa, and Ahmet Yildiz win $50,000 for their innovative work in biomedical science
Researchers used neutron crystallography to visualize the positions and movements of hydrogen atoms in a key enzyme from Helicobacter pylori, which causes stomach cancer. The study provides insights into the enzyme's structure and potential targets for new medications that selectively target H. pylori without harming useful bacteria.
Researchers at Boston Children's Hospital have identified a potential therapeutic solution for age-related fibrosis by pinpointing the gene responsible for the condition. Deletion of the PAD4 gene has been shown to curb fibrosis in mice, reducing organ dysfunction and improving heart function.
A team of researchers at UD has discovered a new function for an enzyme involved in bacterial metabolism. They found that the enzyme plays a major role when generating sugars from non-sugar substrates and facilitates 'back-flow' even when sugar is being consumed.
A new gene therapy has demonstrated effectiveness in clearing glycogen buildup from muscles in mice, potentially replacing enzyme infusions. The therapy uses a modified virus to deliver a gene that produces an enzyme missing in people with Pompe disease.
A recent international multicenter study has identified a molecule that can help personalize treatment for heart failure. Researchers have found that an excess of lysyl oxidase-like 2 produces fibrosis of the cardiac muscle, impeding its normal functioning and stimulating HF development. The elimination of this excess repairs fibrosis ...
A team of researchers from the University of Basel has clarified the role of the enzyme MPO in fighting infections. They found that MPO produces a highly aggressive acid that kills pathogens without damaging surrounding tissue, providing new approaches for immunity strengthening therapies.
Researchers at UT Southwestern Medical Center have identified a novel mechanism by which the stress hormone FGF21 protects the pancreas from damage caused by digestive enzymes. This discovery may lead to new treatments for pancreatitis, a potentially life-threatening inflammation of the pancreas.
A new study uses transgenic organisms and biochemistry to test an evolutionary hypothesis on fruit flies' ability to metabolize alcohol. The research found that the amino acid changes in the ADH protein do not improve the fruit flies' tolerance for alcohol, challenging a previous hypothesis.
Using infrared spectroscopy and computer simulations, researchers at Ruhr-Universität Bochum discovered a magnesium atom contributes significantly to switching G-proteins on and off. This finding has implications for understanding disease mechanisms and developing targeted drugs.
Termite queens have higher antioxidative enzyme levels and lower oxidative damage than other termites, suggesting an anti-aging mechanism that enables their longevity. This efficient antioxidant system allows the queens to live longer despite high fertility.
A study published in Diabetes journal found epigenetic changes in the DPP4 gene are associated with fatty liver development in both mice and humans. These changes, detected at six weeks of age, lead to increased enzyme production and correlate with fat content in the liver.
Researchers at Tufts University have identified over 200 identifiable proteins within firefly nuptial gifts, including structural proteins, enzymes and anti-predator toxins that may influence female reproductive success and paternity rates
Researchers at UConn have developed experimental antibiotics that successfully target and kill MRSA bacteria by blocking the enzyme pathway critical to its survival. By understanding the molecular structure of the enzyme and designing tailored inhibitors, the team created compounds that evade previously resistant strains.
Scientists have discovered metabolons, complex enzyme clusters, for the first time using molecular movie technology. This breakthrough reveals plants' secret medicinal toolbox and unlocks new possibilities for harnessing plant-based medicines.
Researchers used neutrons to determine the structure of an important enzyme in Helicobacter pylori, offering a new point of attack for medications. The findings provide insights into the enzyme's mode of action, enabling the development of molecules that can block this process and target the bacterium effectively.
University of Minnesota researchers have provided unprecedented images of cancer genome-mutating enzymes acting on DNA, offering vital clues into how these enzymes promote tumor evolution. The findings suggest ways to block enzyme activity in cancer, potentially making current anti-cancer therapies more effective.
A recent study discovered that liver cancer drugs fail because the body lacks a balance between two enzymes, Shp2 and Pten. This imbalance activates molecules involved in lipid metabolism, inflammation, and fibrosis, leading to liver disease and cancer.
The study found that human ALOX15 has a higher capacity for producing anti-inflammatory lipid mediators than its lower primate counterparts. This suggests an evolution to better control inflammation and speed up the healing process.
Researchers at Scripps Research Institute discovered that a human enzyme has evolved to change its shape and function without major architectural changes. This unique ability allows the enzyme to carry out new roles in humans, shedding light on diseases linked to mutations in aminoacyl tRNA synthetases.
Researchers found that a SNAP23 inhibitor increases insulin secretion in mice, suggesting a novel therapy for diabetes. The study also showed that SNAP23 promotes vesicle fusion in nonneuronal cells, including pancreatic cells.
Scientists at Cornell University developed a system where enzymes are attached to nanoparticles to mimic the efficient energy-producing mechanism of sperm tails. The tethered enzyme system processes glucose to lactate more efficiently than free-floating enzymes, with potential applications in powering devices that carry out various jobs.
Researchers at Goethe University Frankfurt discovered a new ubiquitination mechanism in Legionella bacteria that affects cellular processes and causes cell death. This mechanism reveals a broader role of ubiquitin in regulating life processes and may lead to new strategies for developing antibacterial agents.
Researchers used CRISPR/Cas9 to remove an enzyme that regulates the diabetes-associated TXNIP gene, leading to reduced cell death and increased insulin production in genetically modified pancreatic beta cells. The study also found that histone acetyltransferases play a crucial role in regulating the TXNIP gene.
Researchers found that individuals lacking the CYP2C19 enzyme have a lower risk of depression and larger hippocampi in adulthood. Increased expression of the enzyme is associated with higher suicidal incidences in depressed patients, suggesting that early life influences may contribute to depression's development.
Researchers at Caltech use directed evolution to persuade bacteria to create silicon-carbon bonds, which are found in pharmaceuticals, agricultural chemicals, and computer screens. The new process has the potential to be more environmentally friendly and less expensive than current methods.
Researchers at Washington University in St. Louis isolated an enzyme GH3.5 that regulates the levels of two plant hormones, auxin and salicylic acid, simultaneously. The study reveals how this single enzyme controls distinct classes of hormones, providing new insights into the molecular pathways for growth and defense.
A new study reveals an efficient means of attaching lipids to peptides, which can improve the molecules' drug-delivery capabilities. This breakthrough enables peptides to be more druglike, overcoming issues with poor absorption and breakdown.